Argenx announces vyvgart™ approval in japan for the treatment of generalized myasthenia gravis

Breda, netherlands--(business wire)--argenx announces vyvgart™ approval in japan for the treatment of generalized myasthenia gravis

ARGX Ratings Summary

ARGX Quant Ranking